Skip to main navigation
Cue Logo
Skip to Content
Cue Logo
  • Overview
  • News & Events
    • News Releases
    • Events and Presentations
  • Corporate Governance
    • Governance Overview
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact Investor Relations

Quarterly
Results

Show all

2023

Q1
  • Cue Health Inc. First Quarter 2023 Earnings Call
  • Cue Health Reports First Quarter 2023 Financial Results
  • Form 10-Q

2022

Q4
  • Cue Health Inc. Fourth Quarter 2022 Earnings Call
  • Cue Health Reports Fourth Quarter and Full-Year 2022 Financial Results
  • Form 10-K
Q3
  • Cue Health Inc. Third Quarter 2022 Earnings Call
  • Cue Health Reports Third Quarter 2022 Results
  • Form 10-Q
Q2
  • Cue Health Inc. Second Quarter 2022 Earnings Call
  • Cue Health Reports Second Quarter 2022 Results
  • Form 10-Q
Q1
  • Cue Health Inc. First Quarter 2022 Earnings Call
  • Cue Health Reports First Quarter 2022 Results
  • Form 10-Q

2021

Q4
  • Cue Health Inc. Fourth Quarter 2021 Earnings Call
  • Cue Health Reports Strong Fourth Quarter and Full Year 2021 Financial Results
  • Form 10-K

Shareholder Tools

Print Page Print Page
Email Alerts Email Alerts
RSS RSS
Contact Contact

This website contains depictions of contemplated future products and future care offerings that are still under development by Cue Health and that have not received regulatory authorization, clearance or approval. Currently, the only products authorized for commercial sale in the United States are Cue Health’s COVID-19 tests, which are currently commercially available in the United States pursuant to two Emergency Use Authorizations from the U.S. Food & Drug Administration.

  • © 2023 Cue Health Inc. All rights reserved. Cue and the Cue logo are registered trademarks of Cue Health Inc.